Regulation of appetite Flashcards

1
Q

When does an individual perceive thirst

A

Body fluid osmolality is increased.
Blood volume is reduced.
Blood pressure is reduced.
Plasma osmolality increased is the more potent stimulus – change of 2-3% induces strong desire to drink.
Decrease of 10-15% in blood volume or arterial pressure required to produce the same response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the action of ADH/ vasopressin

A

Acts on the kidneys to regulate the volume and osmolality of urine.
When plasma ADH is low a large volume of urine is excreted (water diuresis)
When plasma ADH is high a small volume of urine is excreted (anti diuresis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe osmoreceptors and ADH release

A

§ Osmoreceptors are found in the hypothalamus, OVLT (Organum Vasculosum) and SFO (Subfornical Organ).
o These have an incomplete blood-brain barrier (BBB) so they can detect changes in the blood.
o Cells shrink or swell in response to osmolarity and thus send signals to the ADH cells in the hypothalamus to alter ADH release.

The same regions seem to regulate thirst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens when plasma osmolality is increased

A

Invokes drinking and ADH release.

Increased ADH stimulates kidney to conserve water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happens when plasma osmolality is decreased

A

Thirst is suppressed and ADH release decreased

Absence of ADH the kidney excretes more water.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the sensation of thirst

A

Thirst is decreased by drinking even before sufficient water has been absorbed by the GI tract to correct plasma osmolality.
Receptors in mouth, pharynx, oesophagus seem to be involved.
Relief of thirst sensation via these receptors is short lived.
Thirst is only completely satisfied once plasma osmolality is decreased or blood volume or arterial pressure corrected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the 5 primary effects of Ang 2 in the hormonal control of thirst

A

It binds to receptors on vascular smooth muscle cells to stimulate vasoconstriction
It upregulates activity of the sympathetic nervous system, which largely promotes vasoconstriction
It stimulates aldosterone secretion, which increases sodium reabsorption in the nephron, which creates an osmotic gradient for water reabsorption
It directly influences sodium reabsorption, causing water reabsorption
It stimulates ADH release and stimulates thirs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Summarise the hormonal control of thirst

A

Evokes the sensation of thirst
AII is increased when blood volume and pressure are reduced.
Activates SFO neurons
AII contributes to the homeostatic response to restore and maintain the body fluids at their normal level.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the two ways in which thirst can be satisfied

A

Firstly, even the presence of water in the GI tract can quench thirst, for a short period of time at least. This is thought to results from receptors in the upper GI tract (mouth to oesophagus) - short term feedback
Secondly, once the original stimulus (osmolality or blood pressure) has been corrected, then the perception of thirst is no longer felt - long term feedback
These mechanisms are not fully understood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Summarise osmoreceptors

A

Osmoreceptive cells have cell bodies outside of the blood brain barrier that are bathed in the extracellular fluid (ECF). These cells are very sensitive to their local environment and quickly equilibrate with it. If the ECF varies from about 290 mOsm/kg, the cells will proportionately grow (in response to reduced osmolality) or shrink (in response to increased osmolality) by osmosis.
These changes will affect the firing rate of these cells, which will adjust the basal level of ADH being secreted. Increased ADH secretion will lead to water retention (and a decreased osmolality).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the importance of controlling plasma osmolality

A

The osmolality (concentration) of blood is very tightly regulated (285-295 mOsm/kg) to maintain solute gradients, a suitable haematocrit and the ideal viscosity. To achieve this, the kidneys can produce urine of wildly different osmolalities (50-1200 mOsm/kg). For comparison, the desert rat can produce urine of 5000 mOsm/kg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Compare the sensitivity of osmoreceptors to that of baroreceptors

A

The sensing organs for solute concentration are osmoreceptors, which are found in the brain adjacent to structures with an incomplete blood brain barrier. Principally the hypothalamus, within the OVLT and SFO regions.
During (even mild) dehydration, the hypothalamic response is considerably more sensitive than peripheral baroreceptors (which respond to changes in blood volume and pressure). The thresholds for responsive action are as follows:
A 2-3% increase in osmolality
A 10-15% decrease in volume and/or pressure
Physiologically, this is useful because corrective action can be initiated without any critical risk to the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is it important that the hypothalamus has an incomplete blood brain barrier

A

The hypothalamus can combine peripheral signals to elicit a coordinate central response. To achieve this, many regions of the hypothalamus have an incomplete blood brain barrier, which allows sensing organs in hypothalamus to detect increasing and decreasing concentration of circulating gut and appetite regulation hormones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Summarise the role of the hypothalamus in appetite

A

§ The hypothalamus modulates the inputs.
§ You can modify the hypothalamic output voluntarily (like with breathing) but at times when you are not, the hypothalamus takes over.
§ There are LOTS of inputs that are sorted in the hypothalamus.

Inputs include:
Neural input from the periphery and other brain regions
Leptin
GHRELIN, PYY & other gut hormones

Hypothalamus integrates these inputs to control energy expenditure and food intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the important features of the arcuate nucleus

A

Importantly located at the base of the brain, and has an incomplete blood brain barrier, which allows peripheral signals (nutrients, hormones, concentrations, temperature etc.) to directly activate its circuitry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the neuronal populations in the arcuate nucleus

A

The arcuate nucleus has two neuronal populations NPY/Agrp (Neuropeptide Y/Agouti-related peptide) and POMC (proopiomelanocortin). NPY/Agrp neurons stimulate food intake and are located medially. POMC neurons inhibit food intake and are located more laterally. POMC is a long peptide that can be cleaved many ways for many different purposes. The axons from these neurons (whose cell bodies lie in the arcuate nucelus) project to many locations in the brain, but for appetite, a key site is the paraventricular nucelus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is the arcuate nucleus connected to the paraventricular nucleus

A

Via the third ventricle

18
Q

Describe the role of the melanocortin 4 receptor on the paraventricular nuclei

A

Melanocortin 4 receptor (MC4R): paraventricular nucleus receptor that regulates food intake
POMC: cleaved to alphaMSH, binding to agonise the receptor and reduce food intake
Agrp: antagonises the receptor, blocking the satiating signal from alphaMSH to increase food intake

19
Q

Summarise the paraventricular nucleus

A

Paraventricular nucleus: Axons eminating from the arcuate nucleus secrete neuropeptides (Agrp; POMC forms alpha melanocyte stimulating hormone (α-MSH)) that bind to receptors in the paraventricular nucleus. Specifically, the melanocortin 4 receptor (MC4R), which is highly involved in the regulation of food intake. When activated, this receptor decreases food intake behaviours.
α-MSH binds to MC4R, which responds by reducing food intake behaviours
Agrp binds to MC4R and competitively blocks the satieting signal (i.e. I’m full and I don’t need to eat) from α-MSH. This causes an increase in food intake behaviours

20
Q

Describe the mutations affecting appetite

A

§ Mutations:
o No NPY or Agrp mutations have been associated with appetite regulation in humans.
o POMC deficiency and MC4R mutations cause MORBID OBESITY.
§ Brain signals:
o Higher centres, the amygdala (emotion, memory), vagus nerve and other parts of the hypothalamus can all control appetite.
o Dieting is an example of a higher brain function limiting appetite.

21
Q

What is key to remember about these mutations

A

Mutations not responsible for the prevalence of obesity- but useful to explain signalling.

22
Q

Describe leptin

A

Leptin is a hormone that provides long term appetite regulation. It is secreted by cells in white adipose tissue. Leptin binds to receptors in the hypothalamic circuits and stimulates anorexigenic behaviours (i.e. suppresses appetite).
The evolutionary premise of leptin is that a well-nourished adult will accumulate body fat, which in turn increases leptin secretion and suppressing appetite. However, this feedback mechanism can become dysfunctional, as leptin resistance is associated with obesity.

23
Q

Summarise the adipostat mechanism

A

§ Leptin is a circulating hormone produced by white adipose tissue that is detected by the hypothalamus.
§ The hypothalamus can alter neuropeptides to:
o Regulate food appetite (intake).
o Alter thermogenesis (expenditure).

24
Q

How many amino acids in leptin

A

167

25
Q

Describe the different levels of leptin in different situations

A

Low when low body fat
High when high body fat
Replacement in the ob/ob mouse decreases weight.
Hormone that decreases food intake and increases thermogenesis.

26
Q

Describe Three ways in which the leptin regulatory loop could lead to obesity

A

Absent leptin
Leptin resistance
Regulatory defect leading to less leptin

27
Q

Is leptin effective as a weight control drug

A

Leptin circulates in plasma in concentrations proportional to fat mass.
Fat humans have high leptin.
Obesity due to leptin resistance- hormone is present but doesn’t signal effectively.
Leptin is ineffective as a weight control drug.

28
Q

Describe congenital leptin deficiency

A

Small number of cases identified.
Mutation in ob gene- homologous to ob/ob mouse.
Severely hyperphagic and obese.
These people however CAN be given leptin (unlike the leptin resistant obese).

29
Q

Ultimately, why do you feel less hungry after eating a meal

A

Bulk in stomach? …… NO
Nutriments in circulation? … NO

Hormonal Signal from the gut?

30
Q

How is PYY3-36 made

A

PYY3-36 is caused by a truncate between the 2nd and 3rd amino-acid of PYY.

31
Q

Describe PYY3-36

A

Peptitde YY3-36 is the ‘satiety hormone’ and is secreted from cells in the ileum and colon in response to a meal. PYY3-36 binds to hypothalamic receptors and reduces the perception of hunger and the urge to eat.
PYY3-36 is a peptide hormone that regulates short-term appetite control by suppressing eating behaviours.

32
Q

When is PYY3-36 secreted

A

PYY is secreted post-prandial and the levels secreted are proportional the the amount of calories in the meal.
§ PPY3-36 affects the neurones in the arcuate nucleus:
o Inhibits NPY release.
o Stimulates POMC neurones.
§ Thus decreases appetite.

33
Q

Describe the studies on PYY3-36

A

12 Volunteers

PYY3-36 reduced food intake 36%.

34
Q

What is Ghrelin

A

Ghrelin is the ‘hunger hormone’ and is secreted from cells in the stomach in increaisngly higher quantities in the build up to a meal. This is because ghrelin binds to hypothalamic receptors and increases the perception of hunger and the urge to eat.
Ghrelin is a peptide hormone that regulates short-term appetite control by promoting eating behaviours.

35
Q

Describe the action of ghrelin

A

§ Ghrelin drives hunger before a meal and then drops after consumption.
§ Ghrelin affects the neurones in the arcuate nucleus:
o Stimulates NPY/Agrp neurones.
o Inhibits POMC.
§ Thus increases appetite.

36
Q

What may be important in ghrelin structure

A

Fatty acid chain attached to serine 3

May help binding to receptor and how it travels in the circulation

37
Q

Describe the use of gut hormones in obesity treatment

A

Gut hormones may represent a novel treatment for obesity.
Target only relevant circuits.
Released daily without ‘side effects’.
Exert effects throughout life without escape.

High doses- pharmacological adaptation
Narrow therapeutic windows

But there is a drug for GLP-1- approved for obesity and diabetes

38
Q

How is ghrelin released to the brain

A

Via vagus nerve

39
Q

Why are we interested in body weight

A

Obesity is Associated with Comorbidities (stroke, osteoarthritis, depression, M.I, bowel and breast cancers. sleep apnoea, T2DM
10-15% of health budget on these diseases

40
Q

Why do we have a global issue with obesity

A

We live in an obesogenic environment
Genes not had enough time to change
But the effects on the genes has changed

These people who are genetically prone will become obese

41
Q

Describe theories for the obesogenic environment

A

Thrifty Gene Hypothesis:
§ Specific genes are selected for to increase metabolic efficiency and storage of fats.
§ It’s evolutionally sensible to put on weight.
§ Thin humans didn’t survive famines, so didn’t pass on their genes to the modern humans. Adaptive Drift Hypothesis – Due to a NORMAL distribution of body weight:
§ Humans used to be eaten by wild animals. In this time, fat people were eaten and the thin starved, giving a normal distribution of weight.
§ We then learnt to defend ourselves against these animals so the fat people were not eaten but the thin still starved.
o Thus obesity was NOT selected against.
o Putting on body fat was a neutral change and so was never selected against.

42
Q

Outline the link between genes and the environment in obesity

A

Animals and humans with susceptibility genes that render them prone to a multifactorial disease will not manifest the disease phenotype, such as obesity, in a healthy environment. It is only in the presence of a toxic environment that genetic susceptibility will be expressed as the disease phenotype. In a toxic environment, the disease phenotype will emerge in the genetically prone animals or humans, but not in the genetically resistant population. An increase in the frequency or prevalence of a disease phenotype in a toxic environment does not exclude a strong genetic influence on the emergence of the phenotype